Wedbush Maintains Outperform on IBM, Lowers Price Target to $320

Benzinga Newsdesk www.benzinga.com Negative 95.2%

Neg 95.2% Neu 0% Pos 0%

Wedbush analyst Dan Ives maintains IBM (NYSE:IBM) with a Outperform and lowers the price target from $340 to $320.

Comments

No comments yet. Be the first!